Further studies combining advanced neuroimaging modality, including amyloid and tau positron emission tomography (PET) scans and diffusion tractography, in larger PD cohorts with longitudinal follow-ups combing post-mortem pathology studies are warranted to elucidate the deposition and trajectory of amyloid in the development of PDD. Here, MAPT is linked to Parkinson disease.